Inlyta ^*

If you miss a dose of Inlyta, you should skip the missed dose if your next scheduled dose is less than 3 hours away. Do not take two doses at the same time to make up for a missed one. If you vomit after taking a dose, do not take an extra tablet. Simply continue with your next scheduled dose as planned to maintain your treatment schedule.

There is no specific contraindication against drinking alcohol with Inlyta, but it is wise to be cautious. Alcohol can worsen side effects like nausea, fatigue, and diarrhea, which are common with this medication. It is best to discuss your alcohol consumption with your doctor. They can provide personalized advice based on your overall health and treatment plan.

Inlyta tablets should be stored at room temperature, which is between 68°F to 77°F (20°C to 25°C). Keep the medication in its original container with the lid tightly closed. Store it in a dry place away from moisture, heat, and direct sunlight. It is also very important to keep Inlyta and all other medicines out of the reach of children and pets for their safety.

Yes, Inlyta does interact with grapefruit and grapefruit juice. Consuming grapefruit products can increase the amount of Inlyta in your blood, which can raise your risk of serious side effects. Therefore, you should avoid eating grapefruit or drinking grapefruit juice while you are being treated with this medication. Always check with your pharmacist or doctor about potential food and drug interactions before starting a new treatment.

Inlyta is considered a targeted therapy, not a traditional chemotherapy. While both are used to treat cancer, they work in different ways. Traditional chemotherapy kills rapidly dividing cells throughout the body, including healthy ones. Inlyta works more specifically by blocking certain proteins that cancer cells need to grow their own blood supply. This targeted approach can often lead to different side effects than those seen with chemotherapy.

Inlyta begins to work shortly after you start taking it, but the time it takes to see a measurable effect on the cancer can vary. Your oncologist will monitor your progress through imaging scans, such as CT or MRI scans, every few months. These tests help determine how well the medication is controlling the tumor growth. It is important to continue taking the medication as prescribed for it to be effective.

Inlyta can cause harm to an unborn baby and should not be used during pregnancy. Women who are able to become pregnant should use effective birth control during treatment and for at least one week after the final dose. It is not known if Inlyta passes into breast milk, so breastfeeding is not recommended while taking this drug. Discuss your family planning with your doctor before starting treatment.

Hand-foot syndrome is a common side effect of Inlyta that affects the skin on the palms of the hands and soles of the feet. Symptoms can include redness, swelling, tingling, tenderness, and pain. In more severe cases, it can cause blistering and make it difficult to use your hands or walk. Your doctor can recommend ways to manage this side effect, such as using moisturizers and avoiding excessive heat or friction.

Inlyta can cause high blood pressure (hypertension) in many patients, and it can sometimes be severe. Your doctor will monitor your blood pressure regularly while you are on this medication, usually within the first week of starting treatment. If your blood pressure becomes too high, your doctor may prescribe medication to lower it or adjust your dose of Inlyta. It is important to check your blood pressure at home if advised.

Before starting Inlyta, you must tell your doctor about your complete medical history. This includes any issues with your liver, high blood pressure, heart, thyroid, or a history of bleeding or blood clots. Inform them about any upcoming surgeries, as Inlyta may need to be stopped beforehand. Also provide a full list of all medications, supplements, and herbal products you are currently taking to avoid harmful interactions.

You should not take certain pain relievers, like ibuprofen or aspirin, with Inlyta without first consulting your doctor. These nonsteroidal anti-inflammatory drugs (NSAIDs) can increase the risk of bleeding, which is a potential side effect of Inlyta. Your doctor can recommend a safer alternative for pain relief if needed. Always discuss any over-the-counter medications with your healthcare provider before taking them during your cancer treatment.

Inlyta is part of a drug class called tyrosine kinase inhibitors (TKIs) that specifically target the blood vessel growth of tumors. While other TKIs are used for kidney cancer, Inlyta is known for its potent and selective action. Some drugs are immunotherapies that use the body's own immune system to fight cancer. Your doctor chooses the best drug for you based on the cancer stage, your prior treatments, and your overall health.